XML 28 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Income and Comprehensive Income (Loss) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
REVENUES $ 13,971,729 $ 20,957,972
COST OF REVENUES 12,757,365 15,203,140
GROSS PROFIT 1,214,364 5,754,832
OPERATING EXPENSES    
Selling expenses 1,158,467 1,049,529
General and administrative expenses 2,920,303 1,159,099
Research and development expenses 1,899,299 1,468,989
Total operating expenses 5,978,069 3,677,617
(LOSS) INCOME FROM OPERATIONS (4,763,705) 2,077,215
OTHER INCOME (EXPENSE)    
Interest expense (1,709,983) (366,881)
Amortization of debt discounts (645,576) (313,699)
Other income 1,052 36,462
Other expenses   (377,054)
Total other (expenses), net (2,354,507) (1,021,172)
INCOME BEFORE TAXES (7,118,212) 1,056,043
Income tax expense (14,361) (126,984)
NET (LOSS) INCOME (7,132,573) 929,059
Other comprehensive income (loss):    
Foreign currency translation adjustment (5,950) 522,677
Total comprehensive income (loss) $ (7,138,523) $ 1,451,736
Basic (loss) income per share $ (0.35) $ 0.05
Diluted (loss) income per share $ (0.35) $ 0.05
Weighted average number of shares of common stock outstanding – basic 20,278,226 20,000,000
Weighted average number of shares of common stock outstanding –diluted 20,278,226 20,371,428